ATE330615T1 - Doxycyclin zur behandlung von akne - Google Patents

Doxycyclin zur behandlung von akne

Info

Publication number: ATE330615T1
Authority: AT; Austria
Prior art keywords: doxycycline; treating acne; human; acne; administering
Prior art date: 2001-04-05

Application number

AT02731267T

Other languages

English (en)

Inventor

Robert A Ashley

Original Assignee

Collagenex Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-05

Filing date

2002-04-05

Publication date

2006-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE330615(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-05 Application filed by Collagenex Pharm Inc filed Critical Collagenex Pharm Inc

2006-07-15 Application granted granted Critical

2006-07-15 Publication of ATE330615T1 publication Critical patent/ATE330615T1/de

Links

208000002874 Acne Vulgaris Diseases 0.000 title abstract 3
206010000496 acne Diseases 0.000 title abstract 3
229960003722 doxycycline Drugs 0.000 title 1
XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 title 1
-1 tetracycline compound Chemical class 0.000 abstract 2
229940122361 Bisphosphonate Drugs 0.000 abstract 1
239000004098 Tetracycline Substances 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
229960002180 tetracycline Drugs 0.000 abstract 1
229930101283 tetracycline Natural products 0.000 abstract 1
235000019364 tetracycline Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pyrane Compounds (AREA)

AT02731267T 2001-04-05 2002-04-05 Doxycyclin zur behandlung von akne ATE330615T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US28191601P	2001-04-05	2001-04-05

Publications (1)

Publication Number	Publication Date
ATE330615T1 true ATE330615T1 (de)	2006-07-15

Family

ID=23079310

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02731267T ATE330615T1 (de)	2001-04-05	2002-04-05	Doxycyclin zur behandlung von akne

Country Status (12)

Country	Link
EP (4)	EP2221056A1 (de)
JP (3)	JP2004536046A (de)
KR (1)	KR100926326B1 (de)
AT (1)	ATE330615T1 (de)
AU (1)	AU2002303250B2 (de)
CA (2)	CA2719162C (de)
DE (1)	DE60212613T2 (de)
DK (1)	DK1383508T3 (de)
ES (1)	ES2266499T3 (de)
NZ (1)	NZ528197A (de)
PT (1)	PT1383508E (de)
WO (1)	WO2002080932A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2995610A1 (de) *	2002-01-08	2016-03-16	Paratek Pharmaceuticals, Inc.	4-dedimethylamino-tetracyclin-verbindungen
US8192749B2 (en)	2003-04-16	2012-06-05	Galderma Laboratories Inc.	Methods of simultaneously treating ocular rosacea and acne rosacea
CA2476792A1 (en) *	2002-04-16	2003-10-30	Collagenex Pharmaceuticals, Inc.	Methods of simultaneously treating ocular rosacea and acne rosacea
CA2894736C (en)	2003-04-07	2019-07-16	Supernus Pharmaceuticals, Inc.	Once daily formulations of tetracyclines
CN103040773A (zh)	2003-07-25	2013-04-17	沃纳奇尔科特有限责任公司	多西环素金属络合物固体剂型
EP1684768A4 (de) *	2003-11-06	2007-06-06	Univ New York State Res Found	Verfahren zur behandlung von ekzem
US7541347B2 (en)	2007-04-02	2009-06-02	Medicis Pharmaceutical Coropration	Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) *	2005-06-24	2011-04-05	Medicis Pharmaceutical Corporation	Method for the treatment of acne
US8252776B2 (en)	2007-04-02	2012-08-28	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en)	2007-04-02	2009-06-09	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US7704959B2 (en) *	2006-10-03	2010-04-27	Dow Pharmaceutical Sciences	Azithromycin for the treatment of nodular acne
EA016206B1 (ru) *	2007-03-23	2012-03-30	Моликьюлар Рисерч Сентер, Инк.	Композиция и способ лечения воспалительных расстройств
WO2008121107A1 (en) *	2007-04-02	2008-10-09	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
EP2288349A1 (de) *	2008-05-16	2011-03-02	Galderma Research & Development	Therapieplan zur behandlung von erkrankungen in zusammenhang mit akne
WO2010017310A1 (en)	2008-08-06	2010-02-11	Medicis Pharmaceutical Corporation	Method for the treatment of acne and certain dosage forms thereof
US9561241B1 (en)	2011-06-28	2017-02-07	Medicis Pharmaceutical Corporation	Gastroretentive dosage forms for minocycline
HK1206649A1 (en) *	2012-04-19	2016-01-15	Galderma Sa	Method of treating acne
RU2557991C1 (ru) *	2014-05-19	2015-07-27	Вячеслав Владимирович Чеботарёв	Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) *	2017-02-27	2018-08-31	Corporacion Univ Lasallista	Método de encapsulación de tetraciclinas
BR112020000968A2 (pt) *	2017-07-21	2020-07-14	Almirall, Llc	tratamento de lesões não inflamatórias
AU2019205134B9 (en) *	2018-01-07	2025-02-20	Journey Medical Corporation	Minocycline for treating inflammatory skin conditions
US12208123B2 (en)	2019-01-04	2025-01-28	Dermata Therapeutics, Inc.	Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) *	2020-04-20	2021-10-28	国立大学法人大阪大学	免疫賦活化剤、及び治療又は予防用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0086228B1 (de) *	1981-08-27	1988-05-11	Soft Sheen Products, Inc.	Verwendung von carbamidperoxid zur herstellung eines arzneimittels zur behandlung von akne vulgaris
US5122519A (en) *	1989-06-27	1992-06-16	American Cyanamid Company	Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
ATE194492T1 (de) *	1990-08-16	2000-07-15	Bloom Leonard	Topische behandlung von blepharitis
US5674539A (en) *	1994-12-09	1997-10-07	Tomas; Robert E.	Method of treating skin and composition
FR2730930B1 (fr) *	1995-02-27	1997-04-04	Oreal	Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5827840A (en) *	1996-08-01	1998-10-27	The Research Foundation Of State University Of New York	Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) *	1996-08-30	1998-08-04	The Research Foundation Of State University Of New York	Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) *	1998-02-19	1999-06-01	Medics Pharmaceutical Corporation	Method for the treatment of acne
US6432934B1 (en) *	1998-08-06	2002-08-13	Advanced Vision Research	Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) *	1998-09-11	2000-01-18	The Research Foundation Of State University Of New York	Method of using tetracycline compounds to enhance interleukin-10 production
WO2000018353A2 (en) *	1998-09-28	2000-04-06	The Research Foundation Of State University Of New York	A novel inhibitor of cataract formation
US5998390A (en) *	1998-09-28	1999-12-07	The Research Foundation Of State University Of New York	Combination of bisphosphonate and tetracycline
WO2000028983A1 (en) *	1998-11-18	2000-05-25	Collagenex Pharmaceuticals, Inc.	Novel 4-dedimethy laminotetra cycline derivatives
JP2001072660A (ja) *	1999-09-08	2001-03-21	Welfide Corp	ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤

2002
- 2002-04-05 AT AT02731267T patent/ATE330615T1/de active
- 2002-04-05 CA CA2719162A patent/CA2719162C/en not_active Expired - Lifetime
- 2002-04-05 EP EP10159154A patent/EP2221056A1/de not_active Withdrawn
- 2002-04-05 CA CA2440472A patent/CA2440472C/en not_active Expired - Lifetime
- 2002-04-05 JP JP2002578971A patent/JP2004536046A/ja active Pending
- 2002-04-05 AU AU2002303250A patent/AU2002303250B2/en not_active Expired
- 2002-04-05 EP EP02731267A patent/EP1383508B1/de not_active Expired - Lifetime
- 2002-04-05 EP EP06076250A patent/EP1716856A3/de not_active Withdrawn
- 2002-04-05 EP EP06076249A patent/EP1712236A3/de not_active Withdrawn
- 2002-04-05 NZ NZ528197A patent/NZ528197A/en not_active IP Right Cessation
- 2002-04-05 KR KR1020037012965A patent/KR100926326B1/ko not_active Expired - Lifetime
- 2002-04-05 DE DE60212613T patent/DE60212613T2/de not_active Expired - Lifetime
- 2002-04-05 PT PT02731267T patent/PT1383508E/pt unknown
- 2002-04-05 ES ES02731267T patent/ES2266499T3/es not_active Expired - Lifetime
- 2002-04-05 DK DK02731267T patent/DK1383508T3/da active
- 2002-04-05 WO PCT/US2002/010747 patent/WO2002080932A1/en not_active Ceased
2009
- 2009-12-10 JP JP2009280436A patent/JP2010053155A/ja active Pending
2011
- 2011-05-24 JP JP2011115785A patent/JP2011168613A/ja active Pending

Also Published As

Publication number	Publication date
PT1383508E (pt)	2006-11-30
ES2266499T3 (es)	2007-03-01
EP1383508B1 (de)	2006-06-21
EP1712236A3 (de)	2008-05-28
EP1383508A4 (de)	2005-07-06
JP2011168613A (ja)	2011-09-01
NZ528197A (en)	2007-04-27
WO2002080932A1 (en)	2002-10-17
CA2719162A1 (en)	2002-10-17
EP1712236A2 (de)	2006-10-18
EP2221056A1 (de)	2010-08-25
EP1716856A2 (de)	2006-11-02
JP2010053155A (ja)	2010-03-11
DE60212613D1 (de)	2006-08-03
EP1383508A1 (de)	2004-01-28
KR100926326B1 (ko)	2009-11-12
JP2004536046A (ja)	2004-12-02
AU2002303250B2 (en)	2006-05-25
KR20040007488A (ko)	2004-01-24
CA2440472A1 (en)	2002-10-17
CA2719162C (en)	2014-12-23
DK1383508T3 (da)	2006-12-27
CA2440472C (en)	2011-01-18
DE60212613T2 (de)	2007-05-24
EP1716856A3 (de)	2009-02-18

Similar Documents

Publication	Publication Date	Title
ATE330615T1 (de)	2006-07-15	Doxycyclin zur behandlung von akne
WO2005046618A3 (en)	2005-12-29	Methods of treating eczema
DE60142839D1 (de)	2010-09-30	Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
EA200401232A1 (ru)	2005-12-29	Замещенные соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
EA200900540A1 (ru)	2009-12-30	Замещённые соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
ATE271385T1 (de)	2004-08-15	Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
EA201001081A1 (ru)	2011-02-28	Соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
DE69524682D1 (de)	2002-01-31	Mittel zur Behandlung von Wunden
DK0923378T3 (da)	2006-04-03	Fremme af sårheling ved kemisk modificerede tetracykliner
EA200300134A1 (ru)	2003-06-26	Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
WO2003088906A3 (en)	2004-02-26	Methods of simultaneously treating ocular rosacea and acne rosacea
AR037595A1 (es)	2004-11-17	Metodos de tratamiento y formulaciones de cefalosporina
DK0946166T3 (da)	2004-05-03	Anvendelse af matrixmetalloproteinaseinhibitorer til fremme af sårheling
DE60326273D1 (de)	2009-04-02	Verfahren und verbindungen zur verstärkung der fybrozyten-bildung
BR0308813A (pt)	2005-01-04	Tratamento de tuberculose usando derivados de pleuromutilina
ATE191472T1 (de)	2000-04-15	Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen
ATE331527T1 (de)	2006-07-15	Verfahren zur behandlung von brustdrüsenerkrankungen
DE69512589D1 (de)	1999-11-11	Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase
IL162384A0 (en)	2005-11-20	Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
DE69941966D1 (de)	2010-03-11	Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe
DE60237039D1 (de)	2010-08-26	Verfahren zur behandlung von rosacea und telangiectasia
ATE463242T1 (de)	2010-04-15	Behandlung von inkontinenz
ATE393625T1 (de)	2008-05-15	Behandlung und prävention von übermässiger narbenbildung mit 4-hydroxy tamoxifen
ATE262330T1 (de)	2004-04-15	Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs
DE60335093D1 (de)	2011-01-05	Verwendung von nichtantibakteriellen tetrazyklin-analoga und ihren formulierungen für die behandlung von bakteriellen exotoxinen

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1383508

Country of ref document: EP